[Respiratory syncytial virus infections in children].
Respiratory syncytial virus (RSV) is the most frequently isolated agent in acute lower respiratory tract infections in children. It is responsible for severe disease in young infants and patients with immune deficiencies or congenital heart disease, and appears to be involved in sudden death in infancy. There is also some evidence for its involvement in the development of asthma following bronchiolitis. Despite encouraging new therapies (ribavirin, immune globulin, recombinant interferon alfa), treatment remains mainly symptomatic. Hopefully the better understanding of the immune response during VRS infection will allow the development of an effective vaccine in the coming years.